European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2023

6th to 8th December 2023, Geneva, Switzerland and online.

The European Society for Medical Oncology (ESMO) Immuno-Oncology Congress is a global meeting offering an advanced educational programme and the latest scientific developments in this promising field.

From the basics of immunotherapies to the latest research results; from understanding different treatment options to the management of toxicities and interpretation of new data, the ESMO Immuno-Oncology Congress will cater to the diverse needs of oncology stakeholders with an interest in this topical field of cancer treatment.

Take part in this unique meeting to learn, share your research and build invaluable collaborations with fellow experts.

Why Participate

Practice changing data and high quality education in more than 20 tracks covering all tumour types, therapeutic innovations, translational research, patient advocacy, public policy; unrivalled networking opportunities.

Who should attend

Medical/clinical oncologists, basic translational researchers, oncology nurses, all other oncology professionals, patient advocates, journalists, healthcare industry representatives, policy decision makers, regulators.

General Information

Date: 6th to 8th December 2023

Location: Geneva, Switzerland and online.

For more information and detailed program visit the website.


Published in GI-Mail 08/2023 (English edition).

  • Do you already know our monthly newsletter GI-Mail with useful tips on postgraduate courses?
    Sign up here.
  • Are you looking for vacancies or new career challenges? Here you will find the latest vacancies and job offers.
  • Do you already know our monthly job-information GI-Jobs with current job offers for doctors, managers and nurses? Sign up here.
  • Are you interested in up to date postgraduate courses and CME? In our education database »medicine & health« you will find new education events from over 2300 organizers.

    Bildungs-Newsletter

    Job-Newsletter

    Archive

    Comments are closed.